Paper6423014
Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
Jordan VC. Breast Cancer Res Treat, 1983. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications. Papers, record 6423014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6423014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.
- PubMed
- Publication types
- Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Estrogen Antagonists | Major topic |
| 9,10-Dimethyl-1,2-benzanthracene | |
| Animals | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Combined Modality Therapy | |
| Disease Models, Animal | |
| Dose-Response Relationship, Drug | |
| Female | |
| Half-Life | |
| Humans | |
| Mammary Neoplasms, Experimental | |
| Models, Biological | |
| Piperidines | |
| Pyrrolidines | |
| Raloxifene Hydrochloride | |
| Rats | |
| Rats, Inbred Strains | |
| Receptors, Estrogen | |
| Tamoxifen | |
| Thiophenes |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01-CA 20432 | NCI NIH HHS | United States | P01CA020432 | PubMed and NIH | NIH RePORTER |
| P30-CA 14520 | NCI NIH HHS | United States | P30CA014520 | PubMed and NIH | NIH RePORTER |
| R01-CA 32713 | NCI NIH HHS | United States | R01CA032713 | PubMed and NIH | NIH RePORTER |
References63
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 81964 | Tamoxifen and thrombosis. | Lancet | 1978 | https://conductscience.org/library/papers/81964 | PubMed |
| 2 | 1105174 | L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. | N Engl J Med | 1975 | https://conductscience.org/library/papers/1105174 | PubMed |
| 3 | 7397005 | Metabolism of tamoxifen by rat liver microsomes: formation of the N-oxide, a new metabolite. | Biochem Pharmacol | 1980 | https://conductscience.org/library/papers/7397005 | PubMed |
| 5 | 6784425 | Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. | Acta Endocrinol (Copenh) | 1981 | https://conductscience.org/library/papers/6784425 | PubMed |
| 6 | 7198978 | Activity of the antioestrogen trioxifene against N-Nitrosomethylurea-induced rat mammary carcinomas. | Eur J Cancer Clin Oncol | 1981 | https://conductscience.org/library/papers/7198978 | PubMed |
| 7 | 6253058 | Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors. | Cancer Res | 1980 | https://conductscience.org/library/papers/6253058 | PubMed |
| 8 | 7382727 | Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice. | Life Sci | 1980 | https://conductscience.org/library/papers/7382727 | PubMed |
| 9 | 6848356 | Antiestrogen-binding sites distinct from the estrogen receptor: subecellular localization, ligand specificity, and distribution in tissues of the rat. | Endocrinology | 1983 | https://conductscience.org/library/papers/6848356 | PubMed |
| 10 | 7040137 | Mechanisms of oestrogen antagonism by nonsteroidal antioestrogens. | Mol Cell Endocrinol | 1982 | https://conductscience.org/library/papers/7040137 | PubMed |
| 11 | 14163978 | A MOLECULAR BASIS FOR DRUG ACTION. | J Pharm Pharmacol | 1964 | https://conductscience.org/library/papers/14163978 | PubMed |
| 12 | 7053859 | Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth. | Cancer Res | 1982 | https://conductscience.org/library/papers/7053859 | PubMed |
| 13 | 1255105 | Tamoxifen as an anti-tumour agent: oestrogen binding as a predictive test for tumour response. | J Endocrinol | 1976 | https://conductscience.org/library/papers/1255105 | PubMed |
| 14 | 229525 | Estrogen and antiestrogen action in reproductive tissues and tumors. | Recent Prog Horm Res | 1979 | https://conductscience.org/library/papers/229525 | PubMed |
| 15 | 7138577 | Metabolism of tamoxifen by isolated rat hepatocytes: anti-estrogenic activity of tamoxifen N-oxide. | Biochem Pharmacol | 1982 | https://conductscience.org/library/papers/7138577 | PubMed |
| 16 | 7028904 | A high-affinity binding site for the antioestrogens, tamoxifen and CI 628, in immature rat uterine cytosol which is distinct from the oestrogen receptor. | J Endocrinol | 1981 | https://conductscience.org/library/papers/7028904 | PubMed |
| 17 | 1246307 | Combination chemotherapy as an adjuvant treatment in operable breast cancer. | N Engl J Med | 1976 | https://conductscience.org/library/papers/1246307 | PubMed |
| 18 | 7066649 | Adjuvant tamoxifen therapy for early breast cancer: an experimental study with reference to oestrogen and progesterone receptors. | Br J Surg | 1982 | https://conductscience.org/library/papers/7066649 | PubMed |
| 19 | 7359080 | Measurement of tamoxifen in serum by thin-layer densitometry. | J Endocrinol | 1980 | https://conductscience.org/library/papers/7359080 | PubMed |
| 20 | 13716610 | Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression. | Nature | 1961 | https://conductscience.org/library/papers/13716610 | PubMed |
| 21 | 6184101 | Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance. | Breast Cancer Res Treat | 1982 | https://conductscience.org/library/papers/6184101 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39848945 | Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant. | Sci Rep | 2025 | https://conductscience.org/library/papers/39848945 | PubMed |
| 35594462 | Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures. | Cancer J | 2022 | https://conductscience.org/library/papers/35594462 | PubMed |
| 33165800 | Intraductal Injection of Lentivirus Vectors for Stably Introducing Genes into Rat Mammary Epithelial Cells in Vivo. | J Mammary Gland Biol Neoplasia | 2020 | https://conductscience.org/library/papers/33165800 | PubMed |
| 33151906 | 50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened? | Endocr Relat Cancer | 2021 | https://conductscience.org/library/papers/33151906 | PubMed |
| 32580156 | Maternal obesity increases offspring's mammary cancer recurrence and impairs tumor immune response. | Endocr Relat Cancer | 2020 | https://conductscience.org/library/papers/32580156 | PubMed |
| 26052034 | The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy. | Mol Cell Endocrinol | 2015 | https://conductscience.org/library/papers/26052034 | PubMed |
| 25339261 | The new biology of estrogen-induced apoptosis applied to treat and prevent breast cancer. | Endocr Relat Cancer | 2015 | https://conductscience.org/library/papers/25339261 | PubMed |
| 25269699 | Linking estrogen-induced apoptosis with decreases in mortality following long-term adjuvant tamoxifen therapy. | J Natl Cancer Inst | 2014 | https://conductscience.org/library/papers/25269699 | PubMed |
| 24930824 | Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations. | Steroids | 2014 | https://conductscience.org/library/papers/24930824 | PubMed |
| 24659478 | Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer. | Endocr Relat Cancer | 2014 | https://conductscience.org/library/papers/24659478 | PubMed |
| 14680498 | Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. | Breast Cancer Res | 2004 | https://conductscience.org/library/papers/14680498 | PubMed |
| 10705923 | The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens. | J Mammary Gland Biol Neoplasia | 1999 | https://conductscience.org/library/papers/10705923 | PubMed |
| 10051675 | Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10051675 | PubMed |
| 9746215 | The salubrious effect of tamoxifen [correction of Tamaxifen] on serum marker enzymes, glycoproteins, and lysosomal enzymes level in breast cancer woman. | Mol Cell Biochem | 1998 | https://conductscience.org/library/papers/9746215 | PubMed |
| 9205641 | Sex steroids and malignancies. | Osteoporos Int | 1997 | https://conductscience.org/library/papers/9205641 | PubMed |
| 8573710 | Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer. | Breast Cancer Res Treat | 1995 | https://conductscience.org/library/papers/8573710 | PubMed |
| 8504018 | A risk-benefit assessment of tamoxifen therapy. | Drug Saf | 1993 | https://conductscience.org/library/papers/8504018 | PubMed |
| 8242225 | Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer. | Br J Pharmacol | 1993 | https://conductscience.org/library/papers/8242225 | PubMed |
| 8219251 | A model to describe how a point mutation of the estrogen receptor alters the structure-function relationship of antiestrogens. | Breast Cancer Res Treat | 1993 | https://conductscience.org/library/papers/8219251 | PubMed |
| 3328986 | The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect. | Breast Cancer Res Treat | 1987 | https://conductscience.org/library/papers/3328986 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6423014
GET https://conductscience.org/api/papers/v1/6423014/references?page=2